All Posts
An Inspiring Visit To California
Along with hundreds of family and friends (many of them talented musicians), I recently had the privilege to participate in…
A Phase 2a, double-blind, placebo-controlled, multi-center, randomized study evaluating LSTA1 when added to standard of care (SoC) versus standard of care alone in subjects with advanced solid tumors (BOLSTER)
Study Name A Phase 2a, double-blind, placebo-controlled, multi-center, randomized study evaluating LSTA1 when added to standard of care (SoC) versus standard of care…
Patty Maxin's CholangioConnect Experience
As I reflect upon the inception of CholangioConnect, a myriad of emotions flood my being. Unequivocally, I recognize that being…
Five for Friday – Five reasons to participate in Moving for the Cure
Home / Blog / [wpbb post:title] Get ready to lace up your sneakers, stretch those muscles, and join us for…
A Phase 2 study of Futibatinib 20 mg and 16 mg in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements
Study Name A Phase 2 study of Futibatinib 20 mg and 16 mg in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or…
Scientific Update - Circular RNA (circZNF215) in cholangiocarcinoma: A new possible therapeutic target
About 98% of the human genome is non-coding, meaning it does not contain the genetic code to make proteins. However,…
Five for Friday – Five Pages to Review in the Strategic Plan
Home / Blog / [wpbb post:title] The Foundation's Strategic Plan was unveiled at the 10th Annual Cholangiocarcinoma Foundation Conference. Over the next…
The Fourth Annual Quack Out Cholangio 5K Run/Walk Raises Funds for Rare Cancer Research
The 4th Annual Quack Out Cholangio 5k Run/Walk to Crush Bile Duct Cancer was held May 20th at Midnight Oil…
To the “City of Light” then on to “In The Middle Of It All” and “A New Day Every Day”
Wow, talk about a gratifying and full couple of days! As a volunteer for the Cholangiocarcinoma Foundation (CCF), it was…
CCF Celebrates National Cancer Survivors Day - 2023
CCF aligns with the National Cancer Survivors Day Foundation's definition of a survivor as anyone living with a history of…